UK markets close in 3 hours 51 minutes

Partners Group Holding AG (PGHN.SW)

Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
1,210.00+29.00 (+2.46%)
As of 01:22PM CEST. Market open.
Full screen
Previous close1,181.00
Open1,191.50
Bid1,210.00 x 0
Ask1,210.50 x 0
Day's range1,187.50 - 1,215.50
52-week range786.80 - 1,325.50
Volume18,961
Avg. volume50,404
Market cap31.436B
Beta (5Y monthly)1.26
PE ratio (TTM)31.23
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield39.00 (3.30%)
Ex-dividend date24 May 2024
1y target estN/A
  • Business Wire

    Partners Group Acquires a Strategic Minority Stake in Trinity to Support Its Future Growth

    LOS ANGELES, April 15, 2024--Partners Group, a leading global private markets firm, has agreed to acquire a strategic minority stake in Trinity Investments, a U.S. based hospitality-focused real estate investor, to support its future growth. Partners Group will initially target a U.S. $500 million investment with Trinity and will also have the opportunity to commit further capital to Trinity’s North American, European, and special situations investment platforms.

  • Business Wire

    Trinity Investments and Partners Group Acquire The Scottsdale Plaza Resort & Villas

    PARADISE VALLEY, Ariz., April 08, 2024--A joint venture between Partners Group, a leading global private markets firm, acting on behalf of its clients, and funds managed by Trinity Investments ("Trinity"), announced today the acquisition of The Scottsdale Plaza Resort & Villas (the "Resort"), located in Paradise Valley, Arizona.

  • Globe Newswire

    GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organization

    GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organization Since first partnering with GHO in 2019, Sterling Pharma Solutions has grown rapidly, tripling its revenues and quadrupling its earnings. Sterling is now the preferred partner to several leading pharmaceutical companies for handling the development of complex medicines and scaling up of manufacturing Partners Group acquires a significant minority stake, bringing